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Abstract
Objective—Investigate the effects of 12 months of dietary weight loss and/or aerobic exercise on
leukocyte telomere length in postmenopausal women.
Design and Methods—439 overweight or obese women (50–75 y) were randomized to: i)
dietary weight loss (N=118); ii) aerobic exercise (N=117), iii) diet + exercise (N=117), or iv)
control (N=87). The diet intervention was a group-based program with a 10% weight loss goal.
The exercise intervention was 45 mins/day, 5 days/week of moderate-to-vigorous aerobic activity.
Fasting blood samples were taken at baseline and 12 months. DNA was extracted from isolated
leukocytes and telomere length was measured by quantitative-polymerase chain reaction (qPCR).
Mean changes were compared between groups (intent-to-treat) using generalized estimating
equations.
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tResults—Baseline telomere length was inversely associated with age (r=−0.12 p<0.01) and
positively associated with maximal oxygen uptake (r=0.11, p=0.03), but not with BMI or %body
fat. Change in telomere length was inversely correlated with baseline telomere length (r=−0.47,
p<0.0001). No significant difference in leukocyte telomere length was detected in any intervention
group compared to controls, nor was the magnitude of weight loss associated with telomere length
at 12 months.
Conclusions—Twelve-months of dietary weight loss and exercise did not change telomere
length in postmenopausal women.
Keywords
caloric restriction; physical activity; lifestyle; ageing; chromosomes
INTRODUCTION
Telomeres are repetitive DNA sequences that comprise the molecular caps of chromosomes
and help maintain genetic stability (1). With successive cell division, telomeres undergo
incomplete replication leading to gradual shortening; thus, telomere length has been
proposed as a useful marker of biological ageing (2, 3). Indeed, short telomeres have been
associated with several pathologies of ageing including cancer, cardiovascular disease and
dementia (4–7), as well as with early mortality (6, 7).
Inflammation and oxidative stress are known to accelerate telomere length shortening (8);
however the effect of obesity has not been firmly established. Leukocyte telomere length has
been negatively associated with obesity in some (9–13), but not all (14–16), cross-sectional
studies. Telomere lengths appear shorter in physically inactive adults compared to active
peers, and are significantly preserved among physically fit older adults (17). However, little
is known about the effect of weight loss or exercise change on telomere length.
Our purpose was to determine the separate and combined effects of 12 months of dietary
weight loss and/or aerobic exercise on leukocyte telomere length in overweight and obese
postmenopausal women.
METHODS & PROCEDURES
Participants & Interventions
The Nutrition and Exercise in Women (NEW) study was a 12-month randomized controlled
trial testing the effects of caloric restriction and/or exercise on circulating hormones and
other outcomes. Study procedures were reviewed and approved by the Fred Hutchinson
Cancer Research Center Institutional Review Board in Seattle, WA. All participants
provided informed written consent.
The study methods have been previously described (18). Briefly, participants were
postmenopausal women (50–75 y) with a body mass index (BMI) ≥25.0 kg/m2 or ≥23.0 kg/
m2 if Asian-American, recruited through media and mass mailings. Exclusion criteria
included: >100 min/week of moderate physical activity; diagnosed diabetes or other serious
medical condition(s); postmenopausal hormone use; >2 alcoholic drinks/day; current
smoking; participation in another structured weight loss program; contraindication to
participation (e.g. abnormal exercise tolerance test, inability to attend sessions).
Eligible women were randomized to one of: i) reduced-calorie dietary modification
(N=118); ii) moderate-to-vigorous intensity aerobic exercise (N=117); iii) combined diet
and exercise (N=117); or iv) control (no intervention) (N=87) (Figure 1). Computerized
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trandom assignment, using permuted blocks randomization to achieve a proportionally
smaller control group, was stratified according to BMI (≥ or <30kg/m2) and race/ethnicity.
The dietary intervention was a modification of the Diabetes Prevention Program (DPP) (19)
and Look AHEAD (Action for Health in Diabetes) (20) lifestyle behavior change programs
with goals of: 1200–2000 kcal/day, <30% daily calories from fat, and 10% weight loss. The
exercise intervention goal was 45 minutes of moderate-to-vigorous (≥4 metabolic
equivalents [METs]) intensity exercise at a target heart rate of 70–85% observed maximum,
5 days/week. Participants attended three facility-based supervised sessions/week and
exercised 2 days/week at home.
Measures
All study measures were obtained and analyzed by trained personnel who were blinded to
participants’ randomization status.
At baseline (pre-randomization) and 12-months, demographic information, height, weight,
medical history, dietary intake, supplement use and physical activity data were collected.
Body composition was measured by DXA whole-body scanner (GE Lunar, Madison, WI).
Cardiorespiratory fitness (VO2max) was assessed using a maximal graded treadmill test
according to a modified branching protocol (21).
Fasting venous blood (50 mL) was collected during clinic visits (no exercise or non-steroidal
anti-inflammatory medications within 24 hours, no alcohol within 48 hours). Blood was
processed within 1 hour and samples were stored at −80°C. DNA was extracted from
isolated leukocytes using the Qiagen Midi Kit (Qiagen, Valencia, CA). Telomere length was
measured by the quantitative-polymerase chain reaction (qPCR) method (22) (University of
Washington Cytometry and Telomere Cost Center). For each sample, two PCRs were
performed: the first one to amplify the telomeric DNA and the second one to amplify a
single-copy control gene (36B4, acidic ribosomal phosphoprotein PO). This provided an
internal control to normalize the starting amount of DNA. Telomere length was calculated as
the ratio of telomeric DNA divided by the single-copy control gene. All samples were run in
triplicate; the median was used for calculations. For quality assurance, duplicate DNA
samples were included in each batch. Potential outlier samples with extreme long or short
telomeres were repeated to confirm measurements. Inter- and intra-assay variability for
qPCR were 6% and 7%, respectively. Samples were analyzed in batches such that each
participant’s samples were assayed simultaneously, the number of samples from each study
arm were approximately equal, participant randomization dates were similar, and sample
order was random. Two participants (1 control; 1 exercise) were excluded at baseline
because telomere length could not be measured. A comparative analysis of telomere length
measured by qPCR and Southern blot previously reported a high correlation between both
methods (r=0.847, p<0.0001) (23).
Statistical Analysis
All available data were used, without imputation for missing values. Pearson correlation
coefficients were performed between baseline measures. The mean 12-month change in
telomere length in each intervention group was computed and compared to controls using
the generalized estimating equations (GEE) modification of linear regression to account for
intra-individual correlation over time. Intervention effects were examined based on the
assigned treatment at randomization, regardless of adherence or study retention (i.e. intent-
to-treat). Assuming 80% power to make three primary pairwise comparisons (diet+exercise
vs. exercise; diet+exercise vs. diet; and diet vs. exercise), the minimum detectable difference
in telomere length was estimated at 0.082 (type I error=0.05). Based on regression between
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tbaseline age and telomere length, a mean change of −0.005 could be expected in our control
group. Adjustment for multiple comparisons was made using Bonferroni correction (two-
sided alpha=0.05/3). The main analyses were also repeated after stratification by median
split of baseline telomere length. The effect of weight loss on telomere length was examined
using a stratified analysis (<5%, 5–9.9%, and ≥10%) performed within each group and after
combining all intervention groups together. All analyses were adjusted for age and baseline
telomere length (23). Additional confounding by baseline BMI, race/ethnicity or smoking
status (never, former) were also examined. Analyses were performed using SAS software
version 9.2.
RESULTS
At 12-months, 399 participants completed a physical exam, provided a blood sample and
underwent a DXA scan; 40 did not complete the study (Figure 1). Participant characteristics,
intervention adherence, weight loss and body composition changes over 12 months have
been previously published (18). The mean age and BMI were 58.0 years and 30.9 kg/m2.
Most women (65%) were college graduates and 85% were non-Hispanic white. Mean
weight changes were −2.4% (p=0.03) in the exercise group, −8.5% (p<0.001) in the diet
group, and −10.8% (p<0.001) in the diet + exercise group, compared to −0.8% among
controls.
Women randomized to exercise participated in moderate-to-vigorous activity for a mean
(SD) 163.3 (70.6) mins/wk (exercise), and 171.5 (62.9) mins/wk (diet+exercise). Both
groups significantly increased average pedometer steps/day (+2416 and +3471 steps/d,
respectively) and VO2max (+0.17 and +0.12 L/min, respectively) compared to baseline (18).
In both diet groups, women attended an average of 27 diet counseling sessions (86%).
Telomere Length
At baseline, leukocyte telomere length was inversely associated with age (r=−0.12 p<0.01)
(Figure 2) and positively associated with VO2max (r=0.11, p=0.03). Telomere length was
not significantly correlated with BMI (r=0.02, p=0.68) nor % body fat (r=−0.003, p=0.95).
Mean telomere length (SD) was not significantly different between overweight and obese
women (1.045 (0.184) vs. 1.057 (0.201); p=0.63).
The 12-month change in leukocyte telomere length was significantly inversely correlated
with baseline telomere length (r=−0.47, p<0.0001) (Figure 3). However, compared to
controls, there were no significant changes in leukocyte telomere length over 12 months in
any intervention group (Table 1). When the main analyses were stratified according to
baseline telomere length (median split), women with shorter baseline telomere lengths had a
greater mean increase in telomere length over 12 months than those with longer baseline
telomere lengths; however, no interaction effects were statistically significant in any
intervention arm compared to controls (diet: p=0.99; exercise: p=0.32; diet+ex: p=0.63).
The magnitude of weight loss did not significantly affect the 12-month change in telomere
length in any intervention group, or when all intervention arms were combined (Table 2).
Change in telomere length was not associated with baseline VO2max, nor with the 12-month
change in VO2max among women randomized to exercise. Further adjusting the models for
baseline BMI, race/ethnicity or smoking status (never, former) did not meaningfully change
any of the results.
Over 12-months there was a net increase (mean leukocyte telomere length: 0.124, range:
0.002–0.736) in telomere length among 48% (n=190) of women. The proportion of women
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twho experienced a net 12-month increase was not significantly different between groups (χ2
p=0.90).
DISCUSSION
The predominant mechanisms through which obesity may shorten telomere length and
increase risk of ageing-related diseases include heightened oxidative stress, which increases
telomere erosion, and inflammation, which accelerates leukocyte turnover (2). Weight loss
has demonstrated effects on both of these processes (24, 25). However, our results suggest
that 12 months of dietary weight loss and/or aerobic exercise sufficient to yield clinically
meaningful weight loss in a majority of women, did not alter telomere length compared with
controls.
Only a few observational studies have examined the association between adult weight and
telomere length prospectively. Two studies, one including 647 women (35–74 y) (26) and
the other including 70 young African American and white men and women (27) reported
reduced telomere length associated with weight gain over 10 years or more follow-up, while
waist-to-hip ratio was significantly associated with greater rate of telomere shortening over
the subsequent 5 years in 608 patients with stable coronary artery disease (28). Results from
the Finnish Diabetes Prevention Study randomized controlled trial showed only a weak
inverse association (r=−0.12, p=0.03) between leukocyte telomere length and change in BMI
over a mean 4.5 year follow-up in 311 middle-aged adults with impaired glucose tolerance,
with no significant difference between the lifestyle intervention group and controls (29). Lee
et al. (11) previously reported a stronger negative association between obesity and telomere
length in younger compared with older persons. Thus, it is possible that the ability to detect
a significant effect of weight loss was diminished in our relatively homogeneous sample of
postmenopausal women.
A previous study by LaRocca et al. (17) found that leukocyte telomere length was greater in
a small sample (n=17) of endurance-trained older adults (who performed regular vigorous
exercise ≥5 days/week for 5 years or longer) compared to inactive peers (n=15), and was not
significantly different from young exercise-trained adults (n=10). Physical fitness has also
been associated with telomere length in patients with coronary heart disease, such that
patients with low fitness had more than a 2-fold greater odds of having telomere lengths in
the lowest quartile compared to those with high fitness (30). We did not observe a
significant difference in telomere length between controls and women randomized to
exercise for 12 months, despite significant improvements in cardiorespiratory fitness. This
suggests that the exercise dose or duration may have been insufficient to alter telomere
dynamics in our population. It is also possible that underlying genetic factors could
predispose individuals with longer telomeres to exercise or that the underlying biology of
individuals with a history of being overweight and inactive (as our participants were) may
render telomeres less responsive to lifestyle intervention in contrast to the endurance trained
athletes previously studied.
Additionally, our study may have been underpowered to detect significant changes in
telomere length between groups. Given the paucity of available data and the difficulty
directly comparing relative leukocyte telomere length data across studies because of
differences in qPCR methodology, further research is needed to confirm our results.
However, the current results should provide valuable guidance in estimating anticipated
effect sizes in future studies. Although telomeres gradually shorten with age, telomere
length is active and dynamic (31). Thus, 12 months of behavioral intervention may have
been too short a period over which to capture significant change in telomere length.
Furthermore, we did not measure telomerase in this study- a critical enzyme that maintains
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ttelomere length and cellular replicate potential (32). Results from an uncontrolled pilot study
in prostate cancer patients demonstrated a significant increase in telomerase activity after 3
months of intervention involving dietary modification, moderate aerobic activity, stress
management and group support (33). Thus, telomerase may be more sensitive to lifestyle
changes as it also has independent effects on cell and immune function (34).
Although telomere shortening represents a compelling link between genetics, accumulated
lifestyle exposures, obesity and ageing-related diseases, continued research is needed to
determine the degree to which telomere length may be responsive to change through specific
lifestyle interventions.
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• Although dynamic, telomeres undergo progressive shortening with age. They
are proposed as a marker of biological ageing and are associated with outcomes
including cardiovascular diseases and certain cancers.
• Inflammation and oxidative stress accelerate telomere length shortening.
Leukocyte telomere length has been negatively associated with obesity in some,
but not all, cross-sectional studies. Telomere lengths are shorter in physically
inactive adults and are preserved in physically fit adults.
• The degree to which telomere length is amenable to change remains a question
of great interest.
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tWhat this study adds
• A 12-month randomized intervention trial to test the separate and combined
effects of dietary weight loss and/or aerobic exercise on leukocyte telomere
length in overweight and obese postmenopausal women.
• Adds significantly to limited available data on prospective changes in leukocyte
telomere length in response to lifestyle behavior change.
• Demonstrates that twelve months of weight loss and/or exercise is not sufficient
to yield significant changes in telomere length in postmenopausal women.
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Flow of participants through the Nutrition and Exercise in Women (NEW) study.
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Scatterplot diagram of baseline leukocyte telomere length vs. age. r=−0.12 p<0.01.
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tFigure 3.
Scatterplot diagram of baseline leukocyte telomere length vs. 12-month change in leukocyte
telomere length, by intervention group. Control (black circle), Diet (open circle), Exercise
(diamond), Diet + Exercise (triangle). r=0.47, p<0.0001.
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